JEFFREY CARAMEROS: Open Payments
NPI 1457604860 · DUNNELLON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 11 payments from 6 companies in 2025. Trend: 2023 $488 · 2024 $497 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $183 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, NURTEC ODT, TRELEGY ELLIPTA, CAPLYTA, FARXIGA, Rybelsus.
Industry payments across FL — which companies pay providers there.
